Vijaysree Venkatraman

Vijaysree Venkatraman

    Vijee Venkatraman is a Boston-based freelance science journalist. She is a contributor to Beta Boston. Before she became a journalist, she worked on the Human Genome Project at the Broad Institute.

    With 3D Printing, Pharmaceuticals Gain Precision, Potency

    With 3D Printing, Pharmaceuticals Gain Precision, Potency »

    Last month, the FDA approved manufacture of the world’s first 3D printed pill Spritam, an anti-epileptic seizure drug. We caught up with Michael Cima, one of the inventors of 3D printing and a professor at MIT, to find out what this development means for the future of the pharmaceutical industry.

    Send this to a friend